Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT06169215
Title Comparing the Combination of Selinexor-Daratumumab-Velcade-Dexamethasone (Dara-SVD) With the Usual Treatment (Dara-RVD) for High-Risk Newly Diagnosed Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries USA

Facility Status City State Zip Country Details
UCI Health Laguna Hills RECRUITING Laguna Hills California 92653 United States Details
UC Irvine Health/Chao Family Comprehensive Cancer Center RECRUITING Orange California 92868 United States Details
Yale University Cancer Center LAO RECRUITING New Haven Connecticut 06520 United States Details
Yale University RECRUITING New Haven Connecticut 06520 United States Details
Yale-New Haven Hospital North Haven Medical Center RECRUITING North Haven Connecticut 06473 United States Details
Smilow Cancer Hospital Care Center - Waterford RECRUITING Waterford Connecticut 06385 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field